Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Meghan Hibicke"'
Publikováno v:
Psychedelic Medicine. 1:54-67
Autor:
D. Parker Kelley, Lucas Albrechet‐Souza, Shealan Cruise, Rajani Maiya, Aspasia Destouni, Siva S. V. P. Sakamuri, Alexander Duplooy, Meghan Hibicke, Charles Nichols, Prasad V. G. Katakam, Nicholas W. Gilpin, Joseph Francis
Publikováno v:
Genes, Brain and Behavior. 22
Publikováno v:
ACS Chemical Neuroscience. 11:864-871
Psilocybin shows efficacy to alleviate depression in human clinical trials for six or more months after only one or two treatments. Another hallucinogenic drug, esketamine, has recently been U.S. Food and Drug Administration (FDA)-approved as a rapid
Autor:
Katrin H. Preller, Meghan Hibicke, Danilo De Gregorio, Argel Aguilar-Valles, Boris D. Heifets, Gabriella Gobbi, Jennifer M. Mitchell
Publikováno v:
J Neurosci
A revamped interest in the study of hallucinogens has recently emerged, especially with regard to their potential application in the treatment of psychiatric disorders. In the last decade, a plethora of preclinical and clinical studies have confirmed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28946b2ab4e056020a47a80c38781774
https://www.zora.uzh.ch/id/eprint/193169/
https://www.zora.uzh.ch/id/eprint/193169/
Publikováno v:
Experimental and Clinical Psychopharmacology. 25:74-83
Stress during times of rapid development is a risk factor for Major Depressive Disorder, a mood disorder that disproportionately affects women. We developed an adolescent chronic restraint stress (aCRS) protocol using female rats to address the impac
Publikováno v:
The FASEB Journal. 33
Autor:
Charles D. Nichols, Meghan Hibicke
Publikováno v:
The FASEB Journal. 33
Autor:
Meghan Hibicke, Charles D. Nichols
Publikováno v:
The FASEB Journal. 34:1-1
Publikováno v:
The FASEB Journal. 32